NEAT1 and neuroblastoma: The application of ASOs that target the NEAT1 isoform switch region sterically block NEAT1_1 polyadenylation and trigger the loss of NEAT1_1 transcripts concomitant with high levels of the NEAT1_2 isoform, and have a tumour-suppressive effect in neuroblastoma cells.